Different modes of anthracycline interaction with topoisomerase II-Reference-Cited by-同舟云学术

Different modes of anthracycline interaction with topoisomerase II

Published:1993-04 Issue:10 Volume:45 Page:2025-2035
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Jensen Peter Buhl,Sørensen Boe Sandahl,Sehested Maxwell,Demant Erland J.F.,Kjeldsen Eigil,Friche Ellen,Hansen Heine Høi

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference45 articles.

1. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II;Tewey;Science,1984

2. Review. DNA topoisomerase II as the primary target of anti-tumor anthracyclines;Zunino;Anti-Cancer Drug Design,1990

3. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA;Bodley;Cancer Res,1989

4. Antagonistic effect of aclarubicin on daunorubicin induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II;Jensen;Cancer Res,1991

5. Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target;Glisson;Cancer Res,1986

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing;Cancer Chemotherapy and Pharmacology;2024-07-04

2. Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines;Seminars in Cell & Developmental Biology;2020-02

3. Antimicrobial Metallodrugs;Inorganic and Organometallic Transition Metal Complexes with Biological Molecules and Living Cells;2017

4. Aclarubicin;Reference Module in Biomedical Sciences;2017

5. Management of Chemotherapy-Associated Cardiomyopathy;Cardio-Oncology;2017